{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:33:41Z","timestamp":1793504021452,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1186\/s43141-021-00169-4","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T08:03:21Z","timestamp":1620633801000},"page":"66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical impact of PTEN methylation status as a prognostic marker for breast cancer"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-9559","authenticated-orcid":false,"given":"Amal","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menha","family":"Swellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"6","key":"10.1186\/s43141-021-00169-4_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/1947601911423096","article-title":"Cancer epigenetics for the 21st century: what\u2019s next?","volume":"2","author":"Esteller","year":"2011","journal-title":"Genes Cancer"},{"issue":"4","key":"10.1186\/s43141-021-00169-4_bib4","first-page":"246","article-title":"Epigenetics in breast cancer","volume":"35","author":"Atalay","year":"2013","journal-title":"Exp Oncol"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10549-010-1304-2","article-title":"Role of pten promoter methylation in tamoxifen-resistant breast cancer cells","volume":"130","author":"Phuong","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2012.11.103","article-title":"Folic acid enforces DNA methylation mediated transcriptional silencing of pten, apc and rarbeta2 tumour suppressor genes in breast cancer","volume":"430","author":"Lubecka-Pietruszewska","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1186\/s43141-021-00169-4_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13058-014-0450-6","article-title":"DNA methylation profiling in the carolina breast cancer study define cancer subclasses differing in clinicopathologic characteristics and survival","volume":"16","author":"Conway","year":"2014","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1186\/s43141-021-00169-4_bib8","first-page":"2643","article-title":"BRCA1 promoter methylation and clinicopathological characteristics in sporadic breast cancer patients in Indonesia","volume":"19","author":"Harahap","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/iub.1346","article-title":"Aberrant methylation of APC and RAR\u03b22 genes in breast cancer patients","volume":"67","author":"Swellam","year":"2015","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-009-0628-2","article-title":"Gene promoter methylation is associated with increased mortality among women with breast cancer","volume":"121","author":"Xu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1186\/s43141-021-00169-4_bib11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/bjc.2013.136","article-title":"Assessment of DNA methylation status in early stages of breast cancer development","volume":"108","author":"van Hoesel","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1186\/s43141-021-00169-4_bib12","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.2147\/OTT.S111684","article-title":"The association of PTEN hypermethylation and breast cancer: a meta-analysis","volume":"9","author":"Luo","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"6","key":"10.1186\/s43141-021-00169-4_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neo.2018.03.002","article-title":"Clinical significance of PTEN deletion, mutation, and loss of PTEN expression in de novo diffuse large B-cell lymphoma","volume":"20","author":"Wang","year":"2018","journal-title":"Neoplasia"},{"key":"10.1186\/s43141-021-00169-4_bib14","first-page":"3485","article-title":"PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis","volume":"9","author":"Han","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1186\/s43141-021-00169-4_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-319-09614-8_10","article-title":"Understanding the tumor suppressor PTEN in chronic alcoholism and hepatocellular carcinoma","volume":"815","author":"Shearn","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/cancers12030742","article-title":"The role of PTEN loss in immune escape, melanoma prognosis and therapy response","volume":"12","author":"Cabrita","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1186\/s43141-021-00169-4_bib17","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/bjc.2015.169","article-title":"PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma","volume":"112","author":"Beg","year":"2015","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/sjamf.sjamf_28_18","article-title":"Endometrial hyperplasia versus carcinoma: does phosphatase and tensin homolog immunohistochemical expression differentiate between them","volume":"2","author":"El Kholy","year":"2018","journal-title":"Sci J Al-Azhar Med Fac Girls"},{"issue":"19","key":"10.1186\/s43141-021-00169-4_bib19","doi-asserted-by":"crossref","first-page":"32043","DOI":"10.18632\/oncotarget.16761","article-title":"Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/BD-2010-0312","article-title":"Altered transcription and expression of PTEN in breast tumors: is it regulated by hypermethylation?","volume":"33","author":"Shetty","year":"2011","journal-title":"Breast Dis"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ijc.20447","article-title":"PTEN promoter is methylated in a proportion of invasive breast cancers","volume":"112","author":"Khan","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1186\/s43141-021-00169-4_bib22","first-page":"1630","article-title":"Association of aberrant DNA methylation with clinicopathological features in breast cancer","volume":"27","author":"Tserga","year":"2012","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.28021","article-title":"Comprehensive analysis of PTEN status in breast carcinomas","volume":"133","author":"Jones","year":"2013","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/ol.2013.1331","article-title":"Pten mutation, methylation and expression in breast cancer patients","volume":"6","author":"Zhang","year":"2013","journal-title":"Oncol Lett"},{"issue":"21","key":"10.1186\/s43141-021-00169-4_bib25","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1158\/1078-0432.CCR-18-3277","article-title":"DNA methylation markers for breast cancer detection in the developing world","volume":"25","author":"Downs","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1186\/s43141-021-00169-4_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/01.MP.0000095782.79895.E2","article-title":"Methylation profiling of benign and malignant breast lesions and its application to cytopathology","volume":"16","author":"Pu","year":"2003","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1186\/s43141-021-00169-4_bib27","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3892\/ol.2016.5351","article-title":"Aberrant promoter methylation of cancer-related genes in human breast cancer","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1186\/s43141-021-00169-4_bib28","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1007\/s13277-015-4731-1","article-title":"Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran","volume":"37","author":"Yari","year":"2016","journal-title":"Tumor Biol"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jnci\/djz065","article-title":"Blood DNA methylation and breast cancer: a prospective case-cohort analysis in the sister study","volume":"112","author":"Xu","year":"2020","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1186\/s43141-021-00169-4_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43042-019-0025-2","article-title":"Determinants of p14\/ARF methylation in healthy females: association with reproductive and non-reproductive risk factors of breast cancer","volume":"20","author":"Ezzat","year":"2019","journal-title":"Egypt J Med Hum Genet"},{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib31","first-page":"443","article-title":"Promoter methylation of BRCA1, DAPK1 and RASSF1A is associated with increased mortality among Indian women with breast cancer","volume":"19","author":"Yadav","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib32","first-page":"180","article-title":"The staging of cancer: a retrospective and prospective appraisal","volume":"58","author":"Greene","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1186\/s43141-021-00169-4_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0046-8177(95)90010-1","article-title":"Histological grading of breast carcinomas: a study of interobserver agreement","volume":"26","author":"Robbins","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1186\/s43141-021-00169-4_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.pai.0000213135.16783.bc","article-title":"Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy","volume":"15","author":"Phillips","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1186\/s43141-021-00169-4_bib35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4103\/0975-2870.194180","article-title":"Hormone receptor (ER, PR, HER2\/neu) status and proliferation index marker (Ki-67) in breast cancers: their onco-pathological correlation, shortcomings and future trends","volume":"9","author":"Iqbal","year":"2016","journal-title":"Med J DY Patil Univ"},{"issue":"4","key":"10.1186\/s43141-021-00169-4_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"2013","journal-title":"Clin Chem"},{"issue":"3","key":"10.1186\/s43141-021-00169-4_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1040-8428(99)00034-7","article-title":"Pathological prognostic factors in breast cancer","volume":"31","author":"Elston","year":"1999","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0093-7754(01)90045-4","article-title":"New prognostic factors for breast cancer recurrence","volume":"28","author":"Isaacs","year":"2001","journal-title":"Semin Oncol"},{"issue":"7","key":"10.1186\/s43141-021-00169-4_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA153 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.breast.2013.11.003","article-title":"Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer","volume":"23","author":"Wu","year":"2014","journal-title":"Breast"},{"key":"10.1186\/s43141-021-00169-4_bib41","doi-asserted-by":"crossref","unstructured":"Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr, American Society of Clinical Oncology (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. 25(33):5287\u20135312. https:\/\/doi.org\/10.1200\/jco.2007.14.2364","DOI":"10.1200\/JCO.2007.14.2364"},{"issue":"6","key":"10.1186\/s43141-021-00169-4_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000089260","article-title":"Tumor markers in breast cancer\u2014European Group on Tumor Markers recommendations","volume":"26","author":"Molina","year":"2005","journal-title":"Tumor Biol"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2407-13-456","article-title":"Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinicopathological factors in breast tumors","volume":"13","author":"Klajic","year":"2013","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib44","first-page":"59","article-title":"The study of DNA methylation of bax gene promoter in breast and colorectal carcinoma cell lines","volume":"6","author":"Alipour","year":"2013","journal-title":"Iran J Cancer Prev"},{"issue":"15","key":"10.1186\/s43141-021-00169-4_bib45","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/hmg\/ddq199","article-title":"Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations","volume":"19","author":"Barekati","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1186\/s43141-021-00169-4_bib46","first-page":"1178","article-title":"Lack of pten expression in non-small cell lung cancer could be related to promoter methylation","volume":"8","author":"Soria","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1186\/s43141-021-00169-4_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062971","article-title":"Analysis of pten methylation patterns in soft tissue sarcomas by MassARRAY spectrometry","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1186\/s43141-021-00169-4_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/gcc.20062","article-title":"Promoter methylation of the pten gene is a common molecular change in breast cancer","volume":"41","author":"Garc\u00eda","year":"2004","journal-title":"Genes Chromosom Cancer"},{"key":"10.1186\/s43141-021-00169-4_bib49","first-page":"102","article-title":"Promoter hypermethylation of estrogen receptor alpha gene is correlated to estrogen receptor negativity in Iranian patients with sporadic breast cancer","volume":"14","author":"Izadi","year":"2012","journal-title":"Cell J"},{"issue":"1","key":"10.1186\/s43141-021-00169-4_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.31557\/APJCP.2019.20.1.269","article-title":"PTEN genetic and epigenetic alterations define distinct subgroups in north Indian breast cancer patients","volume":"20","author":"Kazim","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"issue":"06","key":"10.1186\/s43141-021-00169-4_bib51","first-page":"6","article-title":"Promoter methylation and loss of expression of PTEN gene in breast cancer patients from Saudi population","volume":"6","author":"Alam","year":"2017","journal-title":"J Clin Exp Oncol"},{"issue":"36","key":"10.1186\/s43141-021-00169-4_bib52","doi-asserted-by":"crossref","first-page":"e8000","DOI":"10.1097\/MD.0000000000008000","article-title":"The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: a meta-analysis","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-021-00169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23007163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23007163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:06:39Z","timestamp":1761660399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23007163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1687157X23007163"],"URL":"https:\/\/doi.org\/10.1186\/s43141-021-00169-4","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of PTEN methylation status as a prognostic marker for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-021-00169-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"66"}}